US 11084798
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted A61PA61P35/00
Quick answer
US patent 11084798 (2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors) held by IDEAYA Biosciences, Inc. expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- IDEAYA Biosciences, Inc.
- Grant date
- Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P35/00